Geldanamycin abrogates ErbB2 association with proteasome-resistant β-catenin in melanoma cells, increases β-catenin-E-cadherin association, and decreases β-catenin-sensitive transcription

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1671-1677

  Bonvini, Paolo ^a,b   An, Won G ^a   Rosolen, Angelo ^b   Nguyen, Phongmai ^a   Trepel, Jane ^a   De Herreros, Antonio Garcia ^c   Dunach, Mireia ^d   Neckers, Leonard M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; GELDANAMYCIN; PROTEASOME; UVOMORULIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CELL MOTILITY; CONTROLLED STUDY; DEPHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOMA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; BENZOQUINONES; BETA CATENIN; CADHERINS; CELL MOVEMENT; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETAL PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; MELANOMA; MULTIENZYME COMPLEXES; NERVE TISSUE PROTEINS; PHOSPHORYLATION; POINT MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-TYROSINE-PHOSPHATASE; QUINONES; RECEPTOR, ERBB-2; RECEPTORS, CELL SURFACE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0035866397     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The cytoplasmic domain of the cell adhesion molecule ovomorulin associates with three independent proteins structurally related in different species
2. The vertebrate adhesive junction proteins β-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties
3. Nuclear localization of β-catenin by interaction with transcription factor LEF-1
4. Functional interaction of β-catenin with the transcription factor LEF-1
5. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos
6. Armadillo dCTF: A marriage made in the nucleus
7. Catenins as mediators of the cytoplasmic functions of cadherins
8. Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion
9. E-Cadherin/Catenin/Cytoskeleton complex: A regulator of cancer invasion
10. A specific domain in α-catenin mediates binding to β-catenin and plakoglobin
11. α-catenin can form asymmetric homodimeric complexes and/or heterodimeric complexes with β-catenin
12. Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-Arc-1:-mechanistic aspects and identification of the antigen as a component related to uvomorulin
13. The role of the cell adhesion molecule ovomorulin in the formation and maintenance of the epithelial junctional complex
14. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
15. Regulation of β-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system
16. Identification of c-MYC as a target of the APC pathway
17. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
18. β-catenin regulates expression of cyctin D1 in colon carcinoma cells
19. β-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
20. Loss of β-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene
21. β-catenin is a target for the ubiquitin-proteasome pathway
22. Stabilization of β-catenin by genetic defects in melanoma cell lines
23. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of β-catenin gene in a human cancer cell line, HSC-39
24. Activation of β-catenin-tcf signaling in colon cancer by mutations in β-catenin or APC
25. Constitutive transcriptional activation by a β-catenin-tcf complex in APC
26. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis
27. Aberrant e-cadherin and α-catenin expression in prostate cancer
28. Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration
29. Cadherin cell adhesion molecules in differentiation and embryogenesis
30. Regulation of e-cadherin/catenin association by tyrosine phosphorylation
31. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorilation of the e-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
32. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells
33. Alterations in β-catenin phosphorylation and plakoglobin expression in human breast cancer cells
34. Clinical and prognostic significance of the expression of the c-erbB2 and c-erbB3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas
35. Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas
36. β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
37. c-erbB2 gene product directly associates with β-catenin and plakoglobin
38. Regulated binding of PTP1B-like phosphatase to N-cadherin: Control of cadherin-mediated adhesion by dephosphorylation of β-catenin
39. Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex
40. The e-cadherin/epidermal growth factor receptor interaction: A hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation
41. Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζ
42. ctn
43. Dominant negative inhibition of the association between β-catenin and c-erbB-2 by N-terminally deleted β-catenin suppresses the invasion and metastasis of cancer cells
44. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome
45. erbB2
46. c-erbB2receptor protein tyrosine kinase induced by geldanamycin
47. Nuclear β-catenin displays GSK-3β- and APC-independent proteasome sensitivity in melanoma cells
48. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway